The frequency of SF3B1 mutations, especially in the highly resistant samples (LC50 ≥ 10 μM), unlike TP53, can be explained by inducing RNA changes belonging to multiple CLL-associated pathways [27]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.